1997The Journal of UrologyRequires access

Prostate Specific Antigen Decreases After Withdrawal of Antiandrogen Therapy with Bicalutamide or Flutamide in Patients Receiving Combined Androgen Blockade

Paul F. Schellhammer, Peter M. Venner, Gabriel P. Haas, Eric Jay Small, Peter T. Nieh, D. Rusby Seabaugh, Anthony L. Patterson, Eric A. Klein, Zev Wajsman, Barry J. A. Furr, Yusong Chen, Geert J.C.M. Kolvenbag

Open publisher page 7 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Bicalutamide, Flutamide, Medicine, Antiandrogen, Blockade, Urology, Prostate-specific antigen, Androgen

Related papers

Back to paper searchBrowse research topicsOriginal source
Prostate Specific Antigen Decreases After Withdrawal of Antiandrogen Therapy with Bicalutamide or Flutamide in Patients Receiving Combined Androgen Blockade — Research Paper | ScholarLens